Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tildrakizumab interleukin-23 biotech NA drugbank Senile Plaques[MeSHID:D058225]
Dental Plaque[MeSHID:D003773]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational antagonist
tildrakizumab interleukin-23 biotech Successful target TTD , drugbank , DGIDB Senile Plaques[MeSHID:D058225]
Dental Plaque[MeSHID:D003773]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 10.61 approved,investigational antagonist
tildrakizumab interleukin-23 biotech Successful target TTD , drugbank , DGIDB Senile Plaques[MeSHID:D058225]
Dental Plaque[MeSHID:D003773]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 10.61 approved,investigational antagonist,inhibitor
tildrakizumab interleukin-37 NA Successful target TTD , DGIDB Senile Plaques[MeSHID:D058225]
Dental Plaque[MeSHID:D003773]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 31.83 approved unknown
click here to return to the previous page